The European Medicines Agency has approved a phase 2 clinical trial for the Respiratory Syncytial Virus (RSV) vaccine, developed by Chilean researchers led by…
Dr. Alexis Kalergis, Director of the Millennium Institute of Immunology and Immunotherapy (MIII) and Full Professor in the Faculties of Biological Sciences and…
The visit by a delegation of distinguished researchers from Tsinghua University—a leading university in China and Asia—aims to foster joint initiatives and…